New weekly shot could help people with obesity shed pounds without diabetes
NCT ID NCT07458269
First seen Jun 27, 2026 · Last updated Jul 16, 2026 · Updated 2 times
Summary
This study tests a new medicine called KAI-9531 (ribupatide) given as a weekly shot to help people with obesity lose weight. It includes 250 adults who have a BMI of 35 or higher and have tried to lose weight before without success. Participants will receive either the drug or a placebo, and researchers will measure how much weight they lose over 48 weeks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kailera Clinical Site
Mesa, Arizona, 85213, United States
-
Kailera Clinical Site
Sun City West, Arizona, 85375, United States
-
Kailera Clinical Site
Irvine, California, 92614, United States
-
Kailera Clinical Site
Lake Forest, California, 92630, United States
-
Kailera Clinical Site
Lomita, California, 90717, United States
-
Kailera Clinical Site
Long Beach, California, 90815, United States
-
Kailera Clinical Site
Montclair, California, 91763, United States
-
Kailera Clinical Site
Rolling Hills Estates, California, 90274, United States
-
Kailera Clinical Site
San Diego, California, 92103, United States
-
Kailera Clinical Site
Santa Ana, California, 92704, United States
-
Kailera Clinical Site
Van Nuys, California, 91405, United States
-
Kailera Clinical Site
DeLand, Florida, 32720, United States
-
Kailera Clinical Site
Orlando, Florida, 32801, United States
-
Kailera Clinical Site
Orlando, Florida, 32803, United States
-
Kailera Clinical Site
The Villages, Florida, 32162, United States
-
Kailera Clinical Site
Decatur, Georgia, 30030, United States
-
Kailera Clinical Site
Woodstock, Georgia, 30189, United States
-
Kailera Clinical Site
Morton, Illinois, 61550, United States
-
Kailera Clinical Site
Indianapolis, Indiana, 46254, United States
-
Kailera Clinical Site
Louisville, Kentucky, 40213, United States
-
Kailera Clinical Site
Rockville, Maryland, 20852, United States
-
Kailera Clinical Site
St Louis, Missouri, 63141, United States
-
Kailera Clinical Site
Lincoln, Nebraska, 68516, United States
-
Kailera Clinical Site
Omaha, Nebraska, 68144, United States
-
Kailera Clinical Site
East Syracuse, New York, 13057, United States
-
Kailera Clinical Site
Greensboro, North Carolina, 27405, United States
-
Kailera Clinical Site
Monroe, North Carolina, 28112, United States
-
Kailera Clinical Site
Raleigh, North Carolina, 27612, United States
-
Kailera Clinical Site
Greenville, South Carolina, 29607, United States
-
Kailera Clinical Site
Myrtle Beach, South Carolina, 29572, United States
-
Kailera Clinical Site
Knoxville, Tennessee, 37909, United States
-
Kailera Clinical Site
Memphis, Tennessee, 38119, United States
-
Kailera Clinical Site
Garland, Texas, 75043, United States
-
Kailera Clinical Site
San Antonio, Texas, 78215, United States
-
Kailera Clinical Site
Winchester, Virginia, 22601, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Timing your meals or halving your rice: a new trial tests simple diet hacks for weight loss and blood sugar control
- Does injection location matter for a new Weight-Loss drug? a trial investigates
- Can a new drug boost Semaglutide's power against diabetes and obesity?
- Can a Normal-Weight baseline improve heart risk assessment in type 1 diabetes?
- A daily pill for obesity? zenagamtide faces its biggest test yet.
- Dance and walking may boost heart health in obesity — a trial puts it to the test